Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion

Retina

Volumn 27, Issue 8, 2007, Pages 1031-1037

  Murakami, Tomoaki ^a   Takagi, Hitoshi ^b,c   Ohashi, Hirokazu ^a   Kita, Mihori ^a   Nishiwaki, Hirokazu ^a   Miyamoto, Kazuaki ^a   Watanabe, Daisuke ^a   Sakamoto, Atsushi ^a   Yamaike, Noritatsu ^a   Yoshimura, Nagahisa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Hyogo Prefectural Amagasaki Hospital   (Japan)

^c HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

Author keywords

Central retinal vein occlusion; Macular edema; Posterior vitreous detachment; Tissue plasminogen activator

Indexed keywords

MONTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; VISUAL ACUITY; VITREOUS BODY DETACHMENT;

AGED; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 37349100816     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318074bc39     Document Type: Article

References (40)

1. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 1995;102:1425-1433.
2. Gutman FA, Zegarra H. Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol 1984; 28:S462-470.
3. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408-415.
4. Vannas S, Orma H. Experience of treating retinal venous occlusion with anticoagulant and antisclerosis therapy. AMA Arch Ophthalmol 1957;58:812-828.
5. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-248.
6. Hayreh SS. So-called "central retinal vein occlusion". II. Venous stasis retinopathy. Ophthalmologica 1976;172:14-37.
7. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 1995;102:1434-1444.
8. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27-55.
9. Kohner EM, Laatikainen L, Oughton J. The management of central retinal vein occlusion. Ophthalmology 1983;90:484-487.
10. Kreutzer A, Brunner R, Schafer HJ, et al. [Thrombolytic therapy with recombinant tissue-type plasminogen activator in patients with branch or central vein occlusion of the retina]. Fortschr Ophthalmol 1988;85:511-513.
11. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc 1996;94:471-504.
12. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-434.
13. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219-223.
14. Ghazi NG, Noureddine B, Haddad RS, et al. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina 2003;23:780-784.
15. Jaffe GJ, Green GD, McKay BS, et al. Intravitreal clearance of tissue plasminogen activator in the rabbit. Arch Ophthalmol 1988;106:969-972.
16. Hesse L, Kroll P. [Enzymatically induced posterior vitreous detachment in proliferative diabetic vitreoretinopathy.] Klin Monatsbl Augenheilkd 1999;214:84-89.
17. Hesse L, Nebeling B, Schroeder B, et al. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res 2000;70:31-39.
18. Sebag J, Balazs EA. Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 1984; 28 Suppl:493-498.
19. Sonoda KH, Sakamoto T, Enaida H, et al. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 2004;111:226-230.
20. Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996;122:258-260.
21. Kiryu J, Kita M, Tanabe T, et al. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology 2001;108:1140-1144.
22. Tachi N, Hashimoto Y, Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 1999;97:465-469.
23. Stefansson E, Novack RL, Hatchell DL. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 1990;31:284-289.
24. Funatsu H, Yamashita H, Ikeda T, et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2003;110:1690-1696.
25. Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996;121:405-413.
26. Loren M, Garcia Frade LJ, Torrado MC, Navarro JL. Thrombus age and tissue plasminogen activator mediated thrombolysis in rats. Thromb Res 1989;56:67-75.
27. Murakami T, Takagi H, Kita M, et al. Intravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2006;142:318-320.
28. Ohashi H, Oh H, Nishiwaki H, et al. Delayed absorption of macular edema accompanying serous retinal detachment after grid laser treatment in patients with branch retinal vein occlusion. Ophthalmology 2004;111:2050-2056.
29. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993;111:1087-1095.
30. Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990;110:118-123.
31. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997;115:486-491.
32. Glacet-Bernard A, Coscas G, Chabanel A, et al. Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 1996;103:551-560.
33. Hart CD, Sanders MD, Miller SJ. Benign retinal vasculitis. Clinical and fluorescein angiographic study. Br J Ophthalmol 1971;55:721-733.
34. Glacet-Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84:609-613.
35. Hikichi T, Yanagiya N, Kado M, et al. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina 1999;19:55-58.
36. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci 2004;45:641-647.
37. Asami T, Terasaki H, Kachi S, et al. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology 2004;111:231-237.
38. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992;99:753-759.
39. Wallow IH, Danis RP, Bindley C, Neider M. Cystoid macular degeneration in experimental branch retinal vein occlusion. Ophthalmology 1988;95:1371-1379.
40. Kishi S, Demaria C, Shimizu K. Vitreous cortex remnants at the fovea after spontaneous vitreous detachment. Int Ophthalmol 1986;9:253-260.